Elizabeth Anne Rollinson
No más puestos en curso
Historial de carrera de Elizabeth Anne Rollinson
Antiguos cargos conocidos de Elizabeth Anne Rollinson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | - | - |
| Phogenix Imaging LLC | Corporate Officer/Principal | - | - |
Antikor Biopharma Ltd.
 Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Director/Miembro de la Junta | 01/04/2006 | - |
Formación de Elizabeth Anne Rollinson.
| Imperial College London | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorial
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
| Phogenix Imaging LLC | |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Health Technology |
